There were 831 press releases posted in the last 24 hours and 358,181 in the last 365 days.

Contact

Please use this form to send email to PR contact of this press release:
Chi-Med Initiates a Phase II Trial of Surufatinib in Combination with Tuoyi in Patients with Advanced Solid Tumors

TO:



FROM:

Please check your email address!

Please, do not fill this field.

Please, do not change this field.

Please, do not fill if your javascript is turned off.

captcha image